Diagnostic-Therapeutic Pathway

Diagnostic-Therapeutic Pathway (DTP) refers to the complete clinical journey of a patient, from the initial presentation of symptoms to diagnosis, treatment, and follow-up care. This concept encompasses every touchpoint where patient data is collected, analyzed, and shared among healthcare professionals. In terms of information security, DTP represents a complex data-sharing ecosystem that requires robust governance to comply with international standards like ISO 27701 and the GDPR. Unlike a static clinical protocol, DTP is dynamic, evolving with the patient's condition, which necessitates continuous monitoring of data-sharing-related risks. For enterprises, this means the DTP must be treated as a series of interconnected data processing activities, each requiring specific controls to prevent unauthorized access or data-sharing errors. This understanding is critical for ensuring both clinical efficacy and regulatory compliance in a digital healthcare environment。

Implementation of DTP in enterprise risk management involves three key steps: First, Data-Flow Mapping—documenting every information exchange point within the DTP, including clinical, administrative, and technical layers. Second, Risk--Based Control Implementation—applying controls such as encryption, access management, and data-sharing protocols at each node, as required by ISO 27701 and NIST frameworks. Third, Continuous Monitoring—establishing KPIs to track data-sharing accuracy and security incidents. For example, a multinational healthcare group implementing DTP-aligned controls saw a 40% reduction in data-related compliance risks within the first year. Key performance indicators (KPIs) include data-sharing error rates (target <0.5%), unauthorized access attempts (target <2 per year), and employee privacy training completion (target 100%). These metrics provide measurable evidence of the DTP's effectiveness in managing information-related risks。

Taiwan enterprises face three primary challenges: Regulatory ambiguity, technical fragmentation, and organizational resistance. The first challenge involves navigating the nuances between the Taiwan Personal Data Protection Act and the GDPR, which can be complex for companies operating both locally and internationally. The second challenge is the lack of standardized data-sharing protocols across different healthcare providers, leading to data silos and increased risk of error. The third challenge is the resistance from clinical staff who may prioritize efficiency over data-sharing protocols. To overcome these, enterprises should adopt international standards like HL7 FHIR for technical interoperability, implement a phased approach starting with high-risk DTP nodes, and invest in comprehensive staff training. A 90-day roadmap starting with a baseline assessment, followed by control implementation and a final audit, is recommended for sustainable success。

Winners Consulting Services Co., Ltd. specializes in Diagnostic-Therapeutic Pathway for Taiwan enterprises, delivering compliant management systems within 90 days. With over 100 successful projects, we provide the expertise needed to navigate both local and international regulations. Free consultation: https://winners.com.tw/contact